About Roxas Pharmaceuticals
Roxas Pharmaceuticals is a Healthcare company. It operates as a manufacturing and marketing of branded and generic pharmaceutical formulations in India. It operates in the Healthcare and Consumer sectors. Its Indian entity Roxas Pharmaceuticals Private Limited reported revenue of ₹33.7 Lakh. Roxas Pharmaceuticals offers products and services including Calcirox-M and Floxi-Kid. Its focus areas include Pharmaceuticals, Drug Manufacturing, Formulations and Quality Assurance.
Company details
Roxas Pharmaceuticals is recognized as a pharmaceutical entity that has been operational since 2014, with its base in Delhi, India. It is involved in the production and distribution of branded and generic formulations across multiple therapeutic segments, supported by a network of over 100 marketing representatives. Quality management is maintained through employee training programs and compliance with Indian Pharmacopeia guidelines for raw materials, processes, and finished products. The companys commitment to high standards is evident in its innovative prescription drug offerings, ensuring reliability in the healthcare sector.
- SectorsHealthcareConsumer
- Email••••••••
- Legal Name Roxas Pharmaceuticals Pvt. Ltd
- Date of Incorporation 26 Mar, 2014
- Jurisdiction Delhi, India
- Annual Revenue₹33.7 Lakh
FY 2024 · +6% YoY
- Net Loss-₹9.7 Lakh
FY 2024 · -29% margin
- EBITDA-₹8.6 Lakh
FY 2024 · -26% margin
Associated legal entities of Roxas Pharmaceuticals
Roxas Pharmaceuticals operates through Roxas Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Roxas Pharmaceuticals Private Limited CIN U74900DL2014PTC267018 | Active | 26 Mar 2014 | Delhi, Delhi | ₹0.3 Cr | – | 2 | View details |
Products & Services of Roxas Pharmaceuticals
Roxas Pharmaceuticals offers a comprehensive portfolio of products and services, including Calcirox-M and Floxi-Kid.
Calcirox-M is manufactured as a branded pharmaceutical product for therapeutic use
Floxi-Kid is marketed as a generic pharmaceutical formulation in various therapeutic areas
Board of directors of Roxas Pharmaceuticals Private Limited (Roxas Pharmaceuticals)
Roxas Pharmaceuticals Private Limited is the primary company behind Roxas Pharmaceuticals. The board of Roxas Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Pradeepkumar Virendrasingh Phougat, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pradeepkumar Virendrasingh Phougat DIN 06825747 | Director | 26 Mar 2014 | 12 yrs 6 mo | Roxas Pharmaceuticals Private Limited |
| Shivani DIN 07911248 | Director | 21 Aug 2017 | 9 yrs 2 mo | Roxas Pharmaceuticals Private Limited |
Financials of Roxas Pharmaceuticals
Figures of Roxas Pharmaceuticals Private Limited, the primary company behind Roxas Pharmaceuticals, for FY 2024. Revenue was ₹33.7 Lakh (+6% year on year). Net loss was -₹9.7 Lakh (-29% margin). EBITDA was -₹8.6 Lakh (-26% margin). Revenue has grown at a compounded annual rate of +9% over three years and +11% over five years.
- ₹33.7 LakhRevenue · FY 2024 · +6% YoY
- -₹9.7 LakhNet loss · -29% margin
- -₹8.6 LakhEBITDA · -26% margin
- ₹1 LakhPaid-up capital
- +9%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Roxas Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Roxas Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Roxas Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Roxas Pharmaceuticals
The primary company behind Roxas Pharmaceuticals, Roxas Pharmaceuticals Private Limited, reported revenue of ₹33.7 Lakh for FY 2024, up 6% year on year.
Roxas Pharmaceuticals is recognized as a pharmaceutical entity that has been operational since 2014, with its base in Delhi, India. It is involved in the production and distribution of branded and generic formulations across multiple therapeutic segments, supported by a network of over 100 marketing representatives. Quality management is maintained through employee training programs and compliance with Indian Pharmacopeia guidelines for raw materials, processes, and finished products. The companys commitment to high standards is evident in its innovative prescription drug offerings, ensuring reliability in the healthcare sector.
Roxas Pharmaceuticals offers Calcirox-M and Floxi-Kid.
Roxas Pharmaceuticals operates through Roxas Pharmaceuticals Private Limited.
The legal entities of Roxas Pharmaceuticals currently have 2 directors, including Shivani, Pradeepkumar Virendrasingh Phougat.